title: [PET and digestive cancers].
abstract: In digestive oncology, the most frequent indication for FDG PET, in our experience and as reported in the literature, is the localisation of recurrent colorectal cancer. This molecular imaging method has also been shown to be clinically useful in various other settings, especially for preoperative staging, for colorectal, esophageal, gastric, pancreatic, hepatic and biliary cancers. We also report on current PET practice in two particular cancers: hepatocellular carcinoma, for which other tracers, including fluoromethylcholine-(18F), are being currently evaluated, and gastrointestinal endocrine tumours, which are included in the recent French marketing authorisation of fluoroDOPA-(18F) and which are also potential targets for radiolabelled somatostatin analogues for PET imaging.
authors.affiliation: Service de médecine nucléaire, AP-HP, Hôpital Tenon, F-75020 Paris, France. jean-noel.talbot@tnn.aphp.fr
authors.forename: Jean-Noël
authors.initials: JN
authors.lastname: Talbot
authors.forename: Françoise
authors.initials: F
authors.lastname: Montravers
authors.forename: Fabrice
authors.initials: F
authors.lastname: Gutman
authors.forename: Khaldoun
authors.initials: K
authors.lastname: Kerrou
authors.forename: Virginie
authors.initials: V
authors.lastname: Huchet
authors.forename: Dany
authors.initials: D
authors.lastname: Grahek
authors.forename: Thierry
authors.initials: T
authors.lastname: Andre
authors.forename: Sydney
authors.initials: S
authors.lastname: Houry
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Touboul
authors.forename: Olivier
authors.initials: O
authors.lastname: Rosmorduc
authors.forename: Raoul
authors.initials: R
authors.lastname: Poupon
authors.forename: Philippe
authors.initials: P
authors.lastname: Ruszniewski
authors.forename: Philippe
authors.initials: P
authors.lastname: Rougier
authors.forename: Jean-Didier
authors.initials: JD
authors.lastname: Grange
mesh_terms: D004067:Digestive System Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology / Q000628:therapy; D019788:Fluorodeoxyglucose F18; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis; D009367:Neoplasm Staging; D049268:Positron-Emission Tomography; D011379:Prognosis; D019275:Radiopharmaceuticals
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18